A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis

Nature Medicine

Volumn 4, Issue 12, 1998, Pages 1383-1391

  Lee, Jong K ^a   Zaidi, Syed H E ^a   Liu, Peter ^b   Dawood, Fayez ^b   Cheah, Alexander Y L ^a   Wen, Wen Hu ^b   Saiki, Yuriko ^a   Rabinovitch, Marlene ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ELASTASE INHIBITOR; UNCLASSIFIED DRUG; ZD 0892;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALOMYOCARDITIS VIRUS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; INFLAMMATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REPERFUSION INJURY; VIRUS MYOCARDITIS;

ADMINISTRATION, ORAL; ANIMALS; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENCEPHALOMYOCARDITIS VIRUS; FIBROSIS; HEART; INFLAMMATION; MALE; MICE; MICE, INBRED DBA; MICROCIRCULATION; MYOCARDITIS; MYOCARDIUM; PERFUSION; PEROXIDASE; PYRROLES; SERINE PROTEINASE INHIBITORS; SULFONAMIDES;

ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS; MURINAE;

EID: 0031728050     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/3973     Document Type: Article

References (44)

1. Fallon, J.T. Myocarditis and dilated cardiomyopathy: Different stages of same disease? in Contemporary issues in Cardiovascular Pathology. Cardiovasc. Clin. Ser. 18, 155-162 (1987).
2. Lieberman, E.B., Hutchins, G.M., Herskowitz, A., Rose, N.R. & Baughman, K.L. Clinicopathologic description of myocarditis. J. Am. Coll. Cardiol. 18, 1617-1626 (1991).
3. Liu, P., Wang E.E.L. & Sole, M. Viral myocarditis: Changing concepts in pathogenesis and implications in diagnosis and treatment. Cardiovasc. Pathol. 2, 247-257 (1993).
4. Tesh, R.B. The prevalence of encephalomyocarditis virus neutralizing antibodies among various human populations. Am. J. Trop. Med. Hyg. 27, 144-149 (1978).
5. Neumann D.A., Burik, K.L., Rose, N.R. & Herskowitz, A. Circulating heart-reactive antibodies in patients with myocarditis and cardiomyopathy. J. Am. Coll. Cardiol. 16, 839-846 (1990).
6. Matsumori, A. & Kawai, C. An animal model of congestive (dilated) cardiomyopathy: Dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 66, 355-360 (1982).
7. Kishimoto, C. & Abelmann, W.H. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury. Circ. Res. 67, 589-598 (1990).
8. Hirasawa, K. et al. Depletion of Mac1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes. J. Gen. Virol. 77, 737-741 (1996).
9. Lane, J.R., Neumann, D.A., Lafond-Walker, A., Herskowitz, A. & Rose, N.R. Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B10.A mice. J. Exp. Med. 175, 1123-1129 (1992).
10. Yamada, T., Matsumori, A. & Sasayama, S. Therapeutic effect of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 89, 846-851 (1994).
11. Takada, H., Kishimoto, C. & Hiraoka, Y. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects. Circulation 92, 1604-1611 (1995).
12. Constanzo-Nordin, M.R., Reap, E.A., O'Connel, J.B., Robinson, J.A. & Scanlon, P.J. A nonsteroidal anti-inflammatory drug exacerbates coxsackievirus B3 murine myocarditis. J. Am. Coll. Cardiol. 6, 1078-1082 (1985).
13. Kishimoto, C. & Abelmann, W.H. Absence of effects of cyclosporine on myocardial lymphocyte subsets in coxsackievirus B3 myocarditis in the aviremic stage. Circ. Res. 65, 934-945 (1989).
14. Kishimoto C., Thorp, K.A. & Abelmann, W.H. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases mortality in murine coxsackievirus B3 myocarditis. Circulation 82, 982-989 (1990).
15. Silver, M.A. & Kowalczyk, D. Coronary microvascular narrowing in acute murine coxsackie B3 myocarditis. Am. Heart J. 118, 173-174 (1989).
16. Factor, S.M., Minase, T., Cho, S., Dominitz, R. & Sonnenblick, E.H. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis. Circulation 66, 342-354 (1982).
17. Dong, R., Liu, P., Wee, L., Butany, J. & Sole, M.J. Verapamil ameliorates the clinical and pathological course of murine myocarditis. J. Clin. Invest. 90, 2022-2030 (1992).
18. Yamada, T., Matsumori, A., Okada, I., Tominaga, M. & Kawai, C. The effect of alpha 1 -blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. Jap. Circ. J. 56, 1138-1145 (1992).
19. Tominaga, M., Matsumori, A., Okada, I., Yamada, T. & Kawai, C. Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice. Circulation 83, 2021-2028 (1991).
20. Rezkalla, S., Kloner, R.A., Khatib, C. & Khatib, R. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis. Circulation 81, 1039-1046 (1990).
21. Harlan, J.M., Killen, P.D., Harker, L.A. & Striker, G.E. Neutrophil-mediated endothelial injury in vitro. J. Clin. Invest. 68, 1394-1403 (1981).
22. Huber, A.R. & Weiss, S.J. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J. Clin. Invest. 83, 1122-1136 (1989).
23. Zimmerman, B.J. & Granger, D.N. Reperfusion-induced leukocyte infiltration: Role of elastase. Am. J. Physiol. 259, H390-H394 (1990).
24. Dinerman, J.L. et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J. Am. Coll. Cardiol. 15, 1559-1563 (1990).
25. Nicolini, F.A. et al. Leukocyte elastase inhibition and t-PA-induced coronary artery thrombolysis in dogs: Beneficial effects on myocardial histology. Am. Heart J. 122, 1245-1251 (1991).
26. Tiefenbacher, C.P., Niroomand, M.E.F., Tillmanns, S.B.H. & Kübler, R.Z.W. Inhibition of elastase improves myocardial function after repetitive ischemia and myocardial infarction in the rat heart. Eur. J. Physiol. 433, 563-570 (1997).
27. Cowan, B. et al. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits after heterotopic cardiac transplantation. J. Clin. Invest. 97, 2452-2468 (1996).
28. Oho, S. & Rabinovitch, M. Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase. Am. J. Pathol. 145, 202-210 (1994).
29. Crinnion, J.N., Homer-Vanniasinkam, S., Hatton, R., Parkin, S.M. & Gough, M.J. Role of neutrophil depletion and elastase inhibition in modifying skeletal muscle reperfusion injury. Cardiovasc. Surg. 2, 749-753 (1994).
30. Edwards, P.D. et al. Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastase. J. Med. Chem. 40, 1876-1885 (1997).
31. Veale, C.A. et al. Orally active trifluoromethyl ketone inhibitors of human leukocyte elastase. J. Med. Chem. 40, 3173-3181 (1997).
32. Molla, A., Hellen, C.U.T. & Wimmer, E. Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. J. Virol. 67, 4688-4695 (1993).
33. Seko, Y., Shinkai, Y. & Kawasaki, A. Expression of perform in infiltrating cells in murine myocarditis caused by coxsackievirus B3. Circulation 84, 788-795 (1991).
34. Caforio A.L.P. et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J. Am. Coll. Cardiol. 15, 1527-1534 (1990).
35. Campbell, E.J., Silverman, E.K. & Campell, M.A. Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143, 2961-2968 (1989).
36. Senior, R.M. et al. Elastase of U-937 monocyte-like cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophage-like cells. J. Clin. Invest. 69, 384-393 (1982).
37. Tschopp, J. & Jogeneel, C.V. Cytotoxic T lymphocyte mediated cytolysis. Biochemistry 27, 2641-2646 (1988).
38. Thompson, K. & Rabinovitch, M. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular matrix-bound basic fibroblast growth factor. J. Cell. Physiol. 166, 495-505 (1996).
39. Romanic, A.M. & Madri, J.A. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125, 1165-1178 (1994).
40. Hauck, M. et al. Effects of synthesized elastin peptides on human leukocytes. Biochem. Mol. Biol. Int. 37, 45-55 (1995).
41. Myers, M.L., Bolli, R., Lekick, R.F., Hartley, C.J. & Roberts, R. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation 72, 915-921 (1985).
42. Frizelle, S., Schwarz, J., Huber, S.A. & Leslie, K. Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. Am. J. Pathol. 141, 203-209 (1992).
43. Bradley, P.P., Priebat, D.A., Christensen, R.D., & Rothstein, C. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206-209 (1982).
44. Keeley, F.W., Morin, J.D. & Vessely, S. Characterization of collagen from normal human sclera. Exp. Eye Res. 39, 533-542 (1984).